RESEARCH & THOUGHTS
Perspectives Shaping Clinical Development
Discover engaging resources driving the conversation forward and on-demand demo videos showcasing the very solutions forming the future of our field.
Specify configurable variables likely to indicate duplicates and review based on similarity scores and...
Download
Rank sites based on performance and tolerance metrics, uncovering ‘at-risk’ locations in need of corrective...
Download
Flag atypical patient patterns, prioritize investigations into anomalies within data sets, and determine...
Download
Identify systematic issues, monitor key metrics, and document deviations from pre-defined QTLs to ensure...
Download
Determine vulnerable trial areas, define risk controls, and monitor capabilities to detect evolving threat...
Download
Assess identified issues, annotate commentary, deploy automatic auditing, and leverage extensive exporting...
Download
- Whitepaper
The Principles of Central Statistical Monitoring
- Whitepaper
Ensuring Trial Validity by Data Quality Assurance and Diversification of Monitoring Methods
- Whitepaper
All you need to know about SMART™, the Engine that Drives CluePoints
- Case Study
Using CluePoints to Reveal Protocol Deviations in Patient Selection
- Case Study
The Value of the CluePoints Solution in Identifying Under-reported Adverse Effects in a Clinical Trial
- Case Study
Using CluePoints to Detect Miscalibrated Equipment in a Clinical Trial
- Case Study
Using CluePoints to Identify Fraud Due to the Fabrication of Patient Diaries
- Case Study
Using CluePoints to Identify Severe Propagation in Vital Sign Measurements
- Case Study
Using CluePoints to Detect Anomalies in Electronic Patient-Reported Outcomes
- Case Study
How CluePoints Detected Fraudulent Reporting of Investigational Product Administration from Patient Diary Data
- Case Study
Leveraging Risk-Based Quality Management to Facilitate Early Risk Detection
- Case Study
How CluePoints Enabled Pfizer’s ‘Hyperspeed’ Vaccine Development
- Blog
ICH E6 R2 – The Clinical R&D Industry’s Response
- Blog
Beyond Risk-Based Monitoring: How Intelligent Analytics Are Being Used To Drive Value And Support ICH Compliance
- Blog
The Bigger Picture Of ICH E6 R2: Looking Beyond Compliance
- Blog
ICH E6 R2: Talking Big Pharma’s Response To The Addendum
- Blog
ICH E6 R2 Roundtable Review – What Does This Mean For The Industry?
- Blog
ICH E6 R2: Waiting And Watching No Longer An Option When It Comes To Risk-Based Monitoring
- Blog
ICH E6 (R2) – Miracle Pill For The Clinical R&D Industry
- Blog
ICH E6 Rev 2 – Ask The Experts
- Blog
Webinar Recording: What Does ICH E6 R2 Mean For Me And My Company?
- Blog
6th Annual CROWN Congress: Sessions You Can’t Afford To Miss + 15% Discount Code
- Blog
Six Ways To Get The Most Out Of Outsourcing In Clinical Trials West Coast ‘17
- Blog
The FDA Is Knocking At Your Door – Are You Ready For An FDA Site Inspection?
